(4-phenoxyphenylsulfonyl)methylthiirane,
SB 3CT compound,
SB-3CT,
SB-3CT compound,
SB-3CT,
292605-14-2,
2-((4-phenoxyphenylsulfonyl)methyl)thiirane,
MMP-2/MMP-9 Inhibitor IV,
SB3CT,
SB 3CT,
CHEMBL483857,
2-[[(4-phenoxyphenyl)sulfonyl]methyl]-Thiirane,
IN1250,
Thiirane, 1,
(4-phenoxyphenylsulfonyl)methylthiirane,
MLS006010722,
Thiirane (deuterium), 1-d2,
GTPL9509,
SCHEMBL2684163,
CHEBI:93782,
CTK8F0499,
KS-00001CWI,
AOB6468,
DTXSID70432359,
EX-A687,
C15H14O3S2,
HMS3653B03,
BCP10428,
2705AH,
BDBM50264809,
MFCD09836266,
s7430,
AKOS026750307,
CS-3445,
inhibitor 1 (Brown et al., 2000),
SB-3CT, >=98% (HPLC), powder,
NCGC00346932-01,
2-(4-phenoxyphenylsulfonylmethyl)thiirane,
AK270339,
HY-12354,
SMR004701685,
RT-015656,
FT-0700278,
SW219838-1,
2-[[(4-Phenoxyphenyl)sulfonyl]methyl]thiirane,
2-[[4-(phenoxy)phenyl]sulfonylmethyl]thiirane,
Thiirane, 2-[[(4-phenoxyphenyl)sulfonyl]methyl]-,
2-[(4-PHENOXYBENZENESULFONYL)METHYL]THIIRANE,
J-017452,
Sb 3ct Compound,
SB-3CT compound,
CID9883002,
C429533,